本文翻译正在准备中。在此之前，我们暂时显示英文原文。
企业公告 · 2026/11/51 分钟阅读
REPEAT – ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
本地自动翻译 · 来源原始语言
摘要
PRINCETON, N.J., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announces a recommended public offer to acquire Egetis Therapeutics AB (publ) (“Egetis”) (the…
来源原始语言: GlobeNewswire — Mergers and Acquisitions打开原始公告 →